Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Longitudinal study of Stenotrophomonas maltophilia antibody levels and outcomes in cystic fibrosis patients.

Longitudinal study of Stenotrophomonas maltophilia antibody levels and outcomes in cystic fibrosis patients.

Resource Type

CF Research News

Authors

Wettlaufer J
Klingel M
Yau Y
Stanojevic S
Tullis E
Ratjen F
Waters V

References

J Cyst Fibros. 2016 Jun 23. pii: S1569-1993(16)30552-5.

Document

PDF icon CF Research News article [1]

Link

Scientific abstract [2]

Keywords

Antibodies [3]
Pulmonary exacerbation [4]
Stenotrophomonas maltophilia [5]

Date

Thursday, June 23, 2016

Featured resource article

Yes
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/longitudinal-study-stenotrophomonas-maltophilia-antibody-levels

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-16-00122R1_FINAL_Waters_07102016.pdf [2] https://www.ncbi.nlm.nih.gov/pubmed/?term=LONGITUDINAL%20STUDY%20OF%20STENOTROPHOMONAS%20MALTOPHILIA%20ANTIBODY%20LEVELS%20AND%20OUTCOMES%20IN%20CYSTIC%20FIBROSIS%20PATIENTS [3] https://www.ecfs.eu/research-article-keywords/antibodies [4] https://www.ecfs.eu/research-article-keywords/pulmonary-exacerbation [5] https://www.ecfs.eu/research-article-keywords/stenotrophomonas-maltophilia